ABX-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameABX-103
Drug Alias Nameanticancer antibody (Abxign)ABX-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbxign Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbxign Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A